News & Updates

Show Multimedia Only
Rosuvastatin on par with atorvastatin in CAD Rosuvastatin on par with atorvastatin in CAD

Rosuvastatin on par with atorvastatin in CAD

06 Nov 2023 byStephen Padilla

Rosuvastatin is as effective as atorvastatin for the composite outcome of all-cause death, myocardial infarction (MI), stroke, or any coronary revascularization at 3 years in adults with coronary artery disease (CAD), according to the secondary analysis of the LODESTAR trial.

06 Nov 2023